YTHDF2 and non-small cell lung carcinoma: The expressions of both YTHDF1 and YTHDF2 were also independent, favorable prognostic factors for recurrence-free survival (HR, 0.745; 95% CI, 0.562–0.984 for YTHDF1; HR, 0.683; 95% CI, 0.503–0.928 for YTHDF2) [66]; however, the molecular mechanism of acting these molecules in NSCLC is unclear.